RIM
GILD icon

Rainier Investment Management’s Gilead Sciences GILD Stock Holding History

Rainier Investment Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-736,626
Closed -$78.4M – 198
2014
Q3 		$78.4M Sell
736,626
-29,010
-4% -$2.84M 1.31% 10
2014
Q2 		$63.5M Sell
765,636
-764,034
-50% -$59.5M 0.98% 25
2014
Q1 		$108M Sell
1,529,670
-738,570
-33% -$57.9M 1.3% 14
2013
Q4 		$170M Sell
2,268,240
-371,250
-14% -$25.9M 1.77% 3
2013
Q3 		$166M Sell
2,639,490
-270,370
-9% -$16.2M 1.61% 5
2013
Q2 		$149M Buy
+2,909,860
New +$152M 1.35% 6

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Rainier Investment Management's GILD Position: Q4 2014 in Review

Rainier Investment Management sold out of Gilead Sciences (GILD) in Q4 2014, closing a stake of 736,626 shares — an estimated $78.4M sold.

Rainier Investment Management first reported a position in GILD in Q2 2013 and held it in 6 quarters. The position peaked at $170M in Q4 2013. 1,438 funds tracked by Wall St. Rank hold GILD as of Q4 2014.

  • Rainier Investment Management reported no remaining Gilead Sciences position as of Q4 2014 after selling out during the quarter.
  • Rainier Investment Management sold 736,626 Gilead Sciences shares in Q4 2014, an estimated $78.4M.
  • Rainier Investment Management first reported a position in Gilead Sciences in Q2 2013 and held it in 6 quarters.
  • Rainier Investment Management's Gilead Sciences position peaked at $170M in Q4 2013.
  • 1,438 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2014.

Based on Rainier Investment Management's 13F filing for Q4 2014, filed 17 Feb 2015.